Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Broderick

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Circulation|October 15, 1995
Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation InvestigatorsM D Ezekowitz, K E James, S M Nazarian, et al.
Neurology|January 6, 2009
Smoking and family history and risk of aneurysmal subarachnoid hemorrhageD Woo, J Khoury, M M Haverbusch, et al.
Stroke|December 1, 1996
An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis StudyB Young, W S Moore, J T Robertson, et al.
Neurology|October 1, 2008
Warfarin use leads to larger intracerebral hematomasM L Flaherty, H Tao, M Haverbusch, et al.
Stroke|April 3, 1999
Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart AssociationJ P Broderick, H P Adams, W Barsan, et al.
Neurology|September 11, 2002
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialA Bruno, S R Levine, M R Frankel, et al.
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Stroke|March 4, 2000
Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhageJ M Gebel, T G Brott, C A Sila, et al.
AJNR. American Journal of Neuroradiology|October 22, 2016
Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization OutcomesT A Tomsick, J Carrozzella, L Foster, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Circulation|October 15, 1995
Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation InvestigatorsM D Ezekowitz, K E James, S M Nazarian, et al.
Neurology|January 6, 2009
Smoking and family history and risk of aneurysmal subarachnoid hemorrhageD Woo, J Khoury, M M Haverbusch, et al.
Stroke|December 1, 1996
An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis StudyB Young, W S Moore, J T Robertson, et al.
Neurology|October 1, 2008
Warfarin use leads to larger intracerebral hematomasM L Flaherty, H Tao, M Haverbusch, et al.
Stroke|April 3, 1999
Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart AssociationJ P Broderick, H P Adams, W Barsan, et al.
Neurology|September 11, 2002
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialA Bruno, S R Levine, M R Frankel, et al.
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Stroke|March 4, 2000
Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhageJ M Gebel, T G Brott, C A Sila, et al.
AJNR. American Journal of Neuroradiology|October 22, 2016
Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization OutcomesT A Tomsick, J Carrozzella, L Foster, et al.
Pageof 9